ICE Intelligent Healthcare key facts
- Manufacturer of intracardiac echo devices intended for structural heart disease and electrophysiology.
- It has raised $5.0M; the latest was Early Stage VC in Feb 2026.
- Notable investors include SND Ventures Group, Dalton Venture, Marathon Venture Partners, Wuhan Jiangxia Technology Investment Group, Hubei Xiachuang Venture Capital Management — 9 tracked in total.
- Status: Privately Held (backing).
Who backs ICE Intelligent Healthcare
9- ·Watch ICE Intelligent Healthcare: the Monday email on marks, rounds and moves
ICE Intelligent Healthcare funding rounds
No funding rounds for ICE Intelligent Healthcare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
ICE Intelligent Healthcare investors
9 investors are on record for ICE Intelligent Healthcare, including SND Ventures Group, Dalton Venture, Marathon Venture Partners and Wuhan Jiangxia Technology Investment Group.
About ICE Intelligent Healthcare
Manufacturer of intracardiac echo devices intended for structural heart disease and electrophysiology. The company offers cardiovascular interventional imaging and provides ICE imaging of heart and blood vessel diseases, as well as during procedures, thereby enabling doctors to improve the effectiveness and safety of surgery during the entire process of cardiovascular disease diagnosis and treatment.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2021
- Employees
- 50
- Website
- ice-intel.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
ICE Intelligent Healthcare doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.